The Valley Desk

NCT02293980 · Interventional trial

A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma (MK-3795-001)

Overall registry status Active not recruiting

Phase 1

Conditions Clear Cell Renal Cell Carcinoma, Kidney Cancer, RCC, Renal Cell Carcinoma, ccRCC

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov